Blmz for tuberculosis, multidrug-resistant

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 8 Dec 2025: Trial registered, NCT07268664

The trials

NCT07268664: Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis:BLMZ Chinese Cohort

State
Not started
Phase
Phase 3
People
120 planned
Started
1 Dec 2025
Primary completion
31 May 2028
Arms
Experimental arm
Results
None posted
  1. 8 Dec 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.